title: [Double-blind trial of oral clodronate in breast cancer patients with bone metastases].
authors.affiliation: Department of medicine, Tom Baker cancer centre, university of Calgary, Edmonton, Canada.
authors.forename: A H
authors.initials: AH
authors.lastname: Paterson
authors.forename: T J
authors.initials: TJ
authors.lastname: Powles
authors.forename: J A
authors.initials: JA
authors.lastname: Kanis
authors.forename: E
authors.initials: E
authors.lastname: McCloskey
authors.forename: J
authors.initials: J
authors.lastname: Hanson
authors.forename: S
authors.initials: S
authors.lastname: Ashley
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002118:Calcium / Q000097:blood / Q000652:urine; D004002:Clodronic Acid / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008875:Middle Aged; D010014:Osteolysis / Q000517:prevention & control
chemical_list: D004002:Clodronic Acid; D002118:Calcium
vernacular_title: Essai en double aveugle du clodronate per os chez des patientes atteintes d'un cancer du sein avec métastases osseuses.